AP
DXCM icon

Anchyra Partners’s DexCom DXCM Stock Holding History

Anchyra Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$718K Sell
10,664
-2,146
-17% -$143K 0.17% 111
2026
Q1 		$804K Sell
12,810
-1,386
-10% -$96.5K 0.24% 88
2025
Q4 		$942K Buy
+14,196
New +$918K 0.29% 71

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.84B AUM 22.63% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Anchyra Partners's DXCM Position: Q2 2026 in Review

Anchyra Partners reduced its DexCom (DXCM) stake by 17% in Q2 2026, selling an estimated $143K and leaving 10,664 shares worth $718K. The position accounts for 0.17% of the portfolio, ranked #111.

Anchyra Partners first reported a position in DXCM in Q4 2025 and has held it in 3 quarters since. The position peaked at $942K in Q4 2025. 496 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Anchyra Partners held 10,664 shares of DexCom worth $718K as of Q2 2026.
  • Anchyra Partners sold 2,146 DexCom shares in Q2 2026, an estimated $143K.
  • DexCom made up 0.17% of Anchyra Partners's portfolio in Q2 2026, its #111 holding.
  • Anchyra Partners first reported a position in DexCom in Q4 2025 and has held it in 3 quarters since.
  • Anchyra Partners's DexCom position peaked at $942K in Q4 2025.
  • 496 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Anchyra Partners's 13F filing for Q2 2026, filed 23 Jul 2026.